## BRK-B: Berkshire Hathaway Inc. New - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.6% below STRENGTH zone (3.0-6.0%); PEG 10.06 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($481.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($54.35M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.2% (+0.8%)
- Blackrock Inc.: 8.4% (+1.0%)
- State Street Corpora: 5.3% (+0.5%)
- Geode Capital Manage: 2.9% (+0.2%)
- Morgan Stanley: 1.9% (-2.3%)

### Key Risks

1. Heavy insider selling: $54M sold (6 transactions in 90 days).
2. Valuation stretched: PEG 10.1x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 10.06 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 18%). Balance sheet: strong liquidity (48.7x), $8.2B free cash flow. Insider selling cluster ($54.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1069.7B |
| Beta | 0.70 |
| 52W Range | $440.10 - $542.07 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 10.06 |
| Forward P/E | 20.5 |
| Current P/E | 23.3 |
| YoY Growth | 13.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.6% over 5 days). Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Underperforming sector by 3.3pp, stock-specific weakness. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram bearish (-2.15), momentum weakening. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.55% (CS: 21) | Neutral |
| RSI_14 | 45.6 | Neutral |
| MACD Histogram | -2.15 | Bearish |
| vs SMA20 | 0.984x | Below |
| vs SMA50 | 0.999x | Below |
| vs SMA200 | 0.995x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $495.85
- **Stop Loss:** $481.31 (2.9% risk)
- **Target:** $510.39 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 94
- **Position Value:** $46,609.90
- **Portfolio %:** 46.61%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-21 (Est: $5.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.73 | $6.25 | +9.0% |
| 2025Q2 | $5.04 | $5.17 | +2.7% |
| 2025Q1 | $4.72 | $4.47 | -5.4% |
| 2024Q4 | $4.19 | $6.73 | +60.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*